Founding Engineer, Roivant Health at Roivant Sciences

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Health TechnologyIndustries

Requirements

Experience building and deploying ML or AI systems in production
Strong Python engineering skills with experience in building scalable, testable codebases
Comfort working in fast-paced, high-ambiguity environments where requirements evolve

Responsibilities

Contribute to technical strategy for new company formation, including scoping early technical feasibility, identifying data and infrastructure needs, and building initial proof-of-concept systems
Design, build, and iterate on tooling, infrastructure, and workflows to run AI/ML training and inference workloads at scale across varied health × AI applications
Develop and refine data and model pipelines that integrate multimodal health data (e.g., clinical text, omics, imaging, sensor data, etc.) for downstream AI/ML tasks
Collaborate closely with domain experts and business stakeholders to incorporate client and commercial insights into model design and deployment

Skills

Key technologies and capabilities for this role

Software EngineeringComputational Drug DiscoveryHealthcare TechnologyData ExchangeBiotech Innovation

Questions & Answers

Common questions about this position

What is the salary or compensation for the Founding Engineer role?

This information is not specified in the job description.

Is this Founding Engineer position remote or does it require office work?

This information is not specified in the job description.

What skills are required for the Founding Engineer position?

The role requires hands-on experience in software engineering, particularly at the intersection of AI, data engineering, and real-world biomedical data, including designing infrastructure for AI/ML workloads, developing data and model pipelines for multimodal health data like clinical text, omics, imaging, and sensor data.

What is the company culture like at Roivant Sciences?

Roivant promotes an open and collaborative culture, embracing diversity across all dimensions, hiring motivated people with diverse backgrounds, and fostering an inclusive environment where employees feel valued, respected, and empowered.

What makes a strong candidate for this Founding Engineer role?

A strong candidate is a talented, hands-on software engineer who is highly entrepreneurial, capable of contributing to technical strategy, scoping feasibility, building proof-of-concepts, and collaborating with business, operational, product, and clinical leaders.

Roivant Sciences

Develops biopharmaceuticals and RNA therapeutics

About Roivant Sciences

Roivant Sciences develops and delivers medicines and technologies aimed at improving patient health, focusing on drug candidates for genetic disorders and RNA therapeutics. The company operates in the biopharmaceutical market, which involves creating drugs from biological sources. Roivant's unique business model combines in-house development with strategic partnerships, allowing it to build a strong pipeline of drug candidates and utilize advanced technologies to meet medical needs. A key subsidiary, Genevant, specializes in RNA therapeutics, employing proprietary delivery platforms for mRNA, RNAi, and gene editing to treat specific diseases. Roivant generates revenue through drug development, licensing agreements, and partnerships, with the goal of bringing innovative treatments to market efficiently.

New York City, New YorkHeadquarters

2014Year Founded

$1,750.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Risks

Integration challenges from Dermavant acquisition may disrupt operations and delay development.

Regulatory hurdles in Pulmovant collaboration with Bayer could impede progress.

Failure of lupus drug brepocitinib may lead to financial losses and investor concerns.

Differentiation

Roivant Sciences focuses on late-stage drug candidates, reducing development time and cost.

The company builds Vants, nimble biotech firms, to enhance drug development efficiency.

Roivant leverages RNA therapeutics, including mRNA and RNAi, for innovative treatments.

Upsides

Roivant's acquisition of Dermavant expands its dermatology portfolio and therapeutic areas.

Strategic partnerships with Bayer and Roche accelerate drug development and market entry.

Increased investment from financial institutions highlights confidence in Roivant's growth potential.

Land your dream remote job 3x faster with AI

Try Jobo Free